Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-04

KARD vs LBRX: stock comparison and AI forecast

Kardigan, Inc. (KARD) and Lb Pharmaceuticals Inc (LBRX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

KARD Kardigan, Inc.

Price
$14.21 -35.6% · 6M
Market Cap
$1.34B
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

LBRX Lb Pharmaceuticals Inc

Price
$40.33 +22.7% · 6M
Market Cap
$1.30B
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-08-11 → 2026-11-03

Six-month price performance

Closing prices rebased to 100 at the start of the window.

75100125150
KARD -35.6% LBRX +22.7%
KARD · LBRX

Key facts

  • KARD and LBRX have similar market capitalizations ($1.34B and $1.30B).
  • Over the last six months LBRX returned +22.7% and KARD -35.6%.
  • KARD carries 0.17 times debt per unit of equity, against 0.09 times for LBRX.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricKARDLBRX
Market Cap$1.34B$1.30B
P/B Ratio2.18x3.91x
EPS–$-4.84
Book Value/Share$6.58$10.30
FCF/Share–$-2.99

Profitability & Margins

MetricKARDLBRX
ROE–-28.8%
ROA–-26.5%
Tax Rate–0.0%

Financial Health

MetricKARDLBRX
Current Ratio8.72x15.08x
D/E Ratio0.17x0.09x
Financial Leverage1.17x1.09x
Working Capital$540M$332M

Cash Flow

MetricKARDLBRX
Operating Cash Flow–-$96M
Free Cash Flow–-$97M
Capital Spending–-$450K

Income Statement

MetricKARDLBRX
Net Income–-$96M
R&D Expense–$76M

Dividend & Shareholder Information

MetricKARDLBRX
Shares Outstanding94M32M
FAQ

KARD vs LBRX: stock comparison and AI forecast

Which is bigger, KARD or LBRX?

KARD and LBRX have similar market capitalizations ($1.34B and $1.30B).

Which stock performed better over the last six months, KARD or LBRX?

Over the last six months LBRX returned +22.7% and KARD -35.6%.

Which one does Intratio's AI model rank higher, KARD or LBRX?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.